INTRODUCTION {#s1}
============

Obstructive jaundice is a clinical syndrome related to bile cholestasis and is governed by complex signals \[[@R1]--[@R3]\]. While historically studied by researching the obstructive jaundice, inputs from the "jaundiced live" and cholestasis impact many functional conditions \[[@R4]--[@R6]\]. Indeed, emerging data suggest that significant progress has been made in understanding the communication between the cholestatic liver diseases and spinal cord in jaundice regulation \[[@R7]--[@R10]\]. The spinal cord is well known to be a complex community of specific genes and long noncoding RNAs (lncRNAs) \[[@R11]--[@R13]\] that profoundly influence many aspects of occurrence and development for pathologic disorders \[[@R14]--[@R20]\], including development of the jaundice regulation. Though there are various studies in clinical disorders by obstructive jaundice, its differential gene and lncRNA expression pattern in the thoracic spinal cord remains unknown.

The introduction of high-throughput RNA sequencing (RNA-seq), where thousands of differential genes and lncRNA expression patterns can be studied in parallel \[[@R21]--[@R24]\], permits a broad assessment for altered expression of differential gene and lncRNA in the lower thoracic spinal cord on different time courses of obstructive jaundice model. In current study, we performed a comprehensive transcriptome analysis in obstructive jaundice model using RNA-seq, and identified lncRNAs with differential expression. To explore the function of lncRNAs, we predicted their potential targets with cis-regulatory effects, which were then put into gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) for further analysis. In addition, we compared the expression of some lncRNAs in thoracic spinal cord at different time points in obstructive jaundice model.

RESULTS {#s2}
=======

Evaluation of jaundice {#s2_1}
----------------------

We observed the general appearance of the animals used in this study (Figure [1](#F1){ref-type="fig"}), and found that rats in BDL group showed yellow ears (D), liver tissue(E) and rear claw(F) 28 days after surgery compared to control group (A, B, C). Otherwise, our results showed that the serum total bilirubin levels was significantly higher in the BDL group (112.8±12.88μml/L) than in the control group (0.45±0.06μml/L) (Figure [1G](#F1){ref-type="fig"}).

![Evaluation of jaundice and the change of nociceptive threshold following BDL operation\
**(A-F)** The rats in BDL group showed yellow ears (D), liver tissue(E) and rear claw(F) 28 days after surgery compared to control group (A, B, C). **(G)** The serum total bilirubin levels was significantly higher in the BDL group (112.8±12.88μml/L) than in the control group (0.45±0.06μml/L). **(H)** The mechanical PWT was tested to assess the jaundice-induced nociceptive threshold change prior to (day 0) and at days 3, 7, 14, 21, and 28 following BDL operation. The hindpaw of BDL rats displayed a dramatic decrease in mechanical PWT to von Frey filament stimulation from 4.28±0.59 g at baseline to 7.15 ±0.43 g 14d after BDL operation and further deteriorated to 7.02 ± 0.57 at day 21, and 7.76 ±0.58g at day 28. ^\*^P\<0.05, ^\*\*^P\<0.01, ^\*\*\*^P\<0.001 compared with the each corresponding time point.](oncotarget-08-106098-g001){#F1}

The change of nociceptive threshold following BDL operation {#s2_2}
-----------------------------------------------------------

The mechanical nociceptive stimulation was tested to assess the jaundice-induced nociceptive threshold change prior to (day 0) and at days 3, 7, 14, 21, and 28 following BDL operation. Our result showed that the hindpaw of BDL rats displayed a dramatic increase in mechanical nociceptive threshold to von Frey filament stimulation from 4.28±0.59 g at baseline to 7.15 ±0.43 g 14d after BDL operation and further deteriorated to 7.02 ± 0.57 at 21d and 7.76 ±0.58g at 28d after BDL operation (Figure [1H](#F1){ref-type="fig"}). These data indicated that obstructive jaundice resulted in the decreased sensitivity in response to the mechanical nociceptive stimulation in the present study.

Differentially expressed genes of T6-T12 spinal cord 28d after BDL operation {#s2_3}
----------------------------------------------------------------------------

To systematically identify jaundice-associated lncRNAs in spinal cord, the differential expression analysis was performed between BDL group and control group. The lncRNA and mRNA expressions of T6-T12 spinal cord of the animals were examined the HiSeq 2000 system (Illumina, Inc.) with a total of 1,198,903,526 raw reads from the nine libraries. Differentially expressed gene profiles in BDL group were compared to the corresponding data from control group. Figure [2](#F2){ref-type="fig"} indicated the scatter plot comparing global mRNA (A) gene expression profiles in the spinal cord between BDL group (Model group) and sham group (Control group), and heat map showing hierarchical clustering of overall mRNA (B) expression pattern of reliably measured probe sets. In addition, heat map also showed hierarchical clustering of mRNA (C), whose expression changes were more than twofold.

![Common bile duct ligation resulted in the expression profiling changes of lncRNA and mRNA\
Scatter plot comparing global mRNA **(A)** gene expression profiles in the spinal cord between BDL group (Model group) and sham group (Control group) rats; Red color is indicative of up-regulated and green color is indicative of down-regulated genes. Black color is indicative of not statistical significant different genes when it does not pass the cutoff values of 1 and −1 in log2 scale. Heat map showing hierarchical clustering of overall mRNA **(B)** expression pattern of reliably measured probe sets. Heat map showing hierarchical clustering of mRNA **(C)**, whose expression changes were more than twofold. In clustering analysis, up- and down-regulated genes are colored in red and green, respectively.](oncotarget-08-106098-g002){#F2}

We identified that a total of 2033 lncRNAs were differentially expressed between control group and BDL group, in which 1545 probe sets were up-regulated and 488 probe sets were down-regulated, whereas a total of 2800 mRNAs were differentially expressed between control group and BDL group, in which 1548 probe sets were up-regulated and 1252 probe sets were down-regulated. The detail information of the top 20 up-regulated and 20 down-regulated lncRNAs was in Table [1](#T1){ref-type="table"}, and that of the top 20 up-regulated and 20 down-regulated mRNAs was in Table [2](#T2){ref-type="table"}. The maximal and minimal fold change was 35.01 and 2.01, respectively.

###### The detail information of the top 20 up-regulated and 20 down-regulated lncRNAs

  Up-regulatedlncRNAs                   Log~2~ fold change(Model/control)   Down-regulatedlncRNAs                 Log~2~ fold change(Model/control)
  ------------------------------------- ----------------------------------- ------------------------------------- -----------------------------------
  *NONRATT025327*                       35.01176765                         *NONRATT025415*                       −27.18649832
  *NONRATT000845*                       22.26444654                         *NONRATT025388*                       −22.79828
  *NONRATT002335*                       20.87539552                         *NONRATT025409*                       −18.60605684
  *NONRATT018085*                       20.23490953                         *NONRATT025389*                       −18.42176407
  *gi\|672030539\|ref\|XR_598272.1\|*   17.2076069                          *NONRATT006517*                       −17.6681701
  *NONRATT001654*                       14.26208272                         *NONRATT012834*                       −11.53074647
  *NONRATT006896*                       13.42852291                         *NONRATT028806*                       −9.221338198
  *gi\|672021044\|ref\|XR_347474.2\|*   12.94719615                         *gi\|672015760\|ref\|XR_599773.1\|*   −9.002940997
  *NONRATT022152*                       12.644969                           *gi\|672089057\|ref\|XR_597824.1\|*   −8.581978626
  *NONRATT030272*                       12.62142301                         *NONRATT018084*                       −7.331131967
  *gi\|672019340\|ref\|XR_601027.1\|*   12.55900993                         *NONRATT023718*                       −6.747783528
  *gi\|672029209\|ref\|XR_596791.1\|*   11.512809                           *NONRATT031185*                       −6.642754333
  *NONRATT011339*                       11.21739711                         *NONRATT029420*                       −6.473944169
  *NONRATT027405*                       11.11711302                         *NONRATT010390*                       −6.470431266
  *NONRATT028521*                       10.78646213                         *NONRATT020020*                       −6.22851892
  *NONRATT006730*                       10.55666403                         *NONRATT013131*                       −6.121677607
  *gi\|672016774\|ref\|XR_600156.1\|*   10.39316965                         *NONRATT006732*                       −5.906932924
  *gi\|672079892\|ref\|XR_596396.1\|*   10.08651117                         *NONRATT019209*                       −5.848382084
  *gi\|672024744\|ref\|XR_599302.1\|*   10.0551937                          *NONRATT022428*                       −5.771813271
  *gi\|672033238\|ref\|XR_349371.2\|*   9.84667827                          *NONRATT022429*                       −5.730278642

###### The detail information of the top 20 up-regulated and 20 down-regulated mRNAs

  Gene symbol                Description                                                    Log~2~ fold change(Model/control)
  -------------------------- -------------------------------------------------------------- -----------------------------------
  **Up-regulated genes**                                                                    
  *Gemin8*                   gem (nuclear organelle) associated protein 8                   23.14275154
  *Serpina3n*                serine (or cysteine) peptidase inhibitor, clade A, member 3N   13.96190308
  *Trim63*                   tripartite motif containing 63, E3 ubiquitin protein ligase    10.67545524
  *Olr728*                   olfactory receptor 728                                         10.23434831
  *Hif3a*                    hypoxia inducible factor 3, alpha subunit                      9.861685919
  *Olr666*                   olfactory receptor 666                                         9.644311752
  *Olr1206*                  olfactory receptor 1206                                        9.628587408
  *Retnla*                   resistin like alpha                                            9.376262216
  *Il6st*                    interleukin 6 signal transducer                                9.164598351
  *Retnlb*                   resistin like beta                                             9.109799277
  *Cxcl17*                   chemokine (C-X-C motif) ligand 17                              8.725497102
  *Reg3b*                    regenerating islet-derived 3 beta                              8.598931015
  *Olr383*                   olfactory receptor 383                                         8.574541671
  *Olr1192*                  olfactory receptor 1192                                        8.391854793
  *Olr1075*                  olfactory receptor 1075                                        8.369125332
  *Tas2r114*                 taste receptor, type 2, member 114                             8.360873477
  *Zbtb16*                   zinc finger and BTB domain containing 16                       8.294338675
  *RGD1309489*               similar to Est1p-like protein B                                8.266135149
  *Olr1063*                  olfactory receptor 1063                                        8.240355839
  *Olr215*                   olfactory receptor 215                                         8.230039718
  **Down-regulated genes**                                                                  
  *Shisa3*                   shisa family member 3                                          −71.14729446
  *Sostdc1*                  sclerostin domain containing 1                                 −47.37907925
  *Sfrp4*                    secreted frizzled-related protein 4                            −32.38831334
  *Smoc2*                    SPARC related modular calcium binding 2                        −29.71653174
  *Smoc2*                    SPARC related modular calcium binding 2                        −25.62228109
  *Mfap4*                    microfibrillar-associated protein 4                            −25.00123131
  *Col1a1*                   collagen, type I, alpha 1                                      −20.63943781
  *Gxylt2*                   glucoside xylosyltransferase 2                                 −18.03100637
  *Col15a1*                  collagen, type XV, alpha 1                                     −17.56597588
  *Igfbp5*                   insulin-like growth factor binding protein 5                   −15.10090131
  *Selp*                     selectin P                                                     −14.44927067
  *Cdh1*                     cadherin 1                                                     −14.28981311
  *Col12a1*                  collagen, type XII, alpha 1                                    −14.02389161
  *Scin*                     scinderin                                                      −14.00885112
  *Wisp1*                    WNT1 inducible signaling pathway protein 1                     −13.78032056
  *Col6a3*                   collagen, type VI, alpha 3                                     −13.72869989
  *Col3a1*                   collagen, type III, alpha 1                                    −13.16577469
  *Loxl1*                    lysyl oxidase-like 1                                           −12.37937746
  *Smim5*                    small integral membrane protein 5                              −11.67644662
  *Prdm6*                    PR domain containing 6                                         −11.448275

Gene ontology annotation for differential expression genes {#s2_4}
----------------------------------------------------------

We had used the RNA-seq analyses to identify the differentially expressed genes which were annotated using the GO database (Gene Ontology,<http://www.geneontology.org/>). The present study showed three important results involved in biological functional groups including molecular function (Figure [3A](#F3){ref-type="fig"}), biological process (Figure [3B](#F3){ref-type="fig"}), and cellular component (Figure [3C](#F3){ref-type="fig"}). Figure [3D](#F3){ref-type="fig"} indicated that the differential expression genes were analyzed with GO background significant enrichment, and the differentially expressed mRNAs in spinal cord were primarily involved in the biological processes GO functions (Figure [4](#F4){ref-type="fig"}).

![The differential expression of mRNAs in spinal cord after common bile duct ligation-induced jaundice model was analyzed by Gene Ontology (GO) annotation and enrichment\
**(A)** molecular function classification; **(B)** biological process classification; **(C)** cellular component classification. **(D)** The differential expression genes were analyzed with GO background significant enrichment. Solid bar represents target genes set, slash bar represents genes set.](oncotarget-08-106098-g003){#F3}

![Pathway analysis for differential expression of mRNAs in spinal cord after common bile duct ligation-induced jaundice model](oncotarget-08-106098-g004){#F4}

Validation of the lncRNAs by RT-qPCR 28d after BDL operation {#s2_5}
------------------------------------------------------------

To validate the RNA-seq data, top 5 up-regulated lncRNAs (NONRATT025327, NONRATT000845, NONRATT001654, NONRATT002335, and NONRATT018085) and top 5 down-regulated lncRNAs (NONRATT025415, NONRATT025388, NONRATT025409, NONRATT02538 and NONRATT006517) that were differentially expressed between BDL group and control group were randomly selected (Table [3](#T3){ref-type="table"}), and their relative expression levels were quantified by RT-qPCR. We found that the expressions of lncRNA NONRATT002335 and NONRATT018085 were significantly up-regulated underlying BDL group compared with control group, whereas the expression of lncRNA NONRATT025415, NONRATT025388 and NONRATT025409 was significantly down-regulated in model group (Figure [5](#F5){ref-type="fig"}).

###### Top 5 up-regulated lncRNAs

  ProbeName                      log2Fold change (Model group/control group)   GeneID            Product length
  ------------------------------ --------------------------------------------- ----------------- ----------------
  NONRATT025327                  35.0117676468596                              NONRATG020647.2   150
  NONRATT000845                  22.2644465403801                              NONRATG000689.2   212
  NONRATT002335                  20.8753955158768                              NONRATG001912.2   150
  NONRATT018085                  20.2349095300728                              NONRATG014750.2   81
  NONRATT001654                  14.2620827239878                              NONRATG001356.2   132
  Top 5 down-regulated lncRNAs                                                                   
  NONRATT025415                  27.1864983217999                              NONRATG020725.2   120
  NONRATT025388                  22.7982799999892                              NONRATG020701.2   89
  NONRATT025409                  18.6060568387294                              NONRATG020719.1   111
  NONRATT025389                  18.4217640674687                              NONRATG020702.2   131
  NONRATT006517                  17.6681700975811                              NONRATG005240.2   95

![Validation of the lncRNAs by RT-qPCR 28d after BDL operation\
The expressions of lncRNA NONRATT002335 and NONRATT018085 were significantly up-regulated underlying BDL group compared with control group, whereas the expression of lncRNA NONRATT025415, NONRATT025388 and NONRATT025409 was significantly down-regulated in model group.](oncotarget-08-106098-g005){#F5}

The expression of 10 lncRNAs in T6-T12 spinal cord at different time points (14d/28d) after BDL operation {#s2_6}
---------------------------------------------------------------------------------------------------------

Obviously, gene expressions after BDL operation injection are varied in different time points. We collected spinal tissue sample from T6-T12 spinal cord 14d vs 28d after BDL operation for RT-qPCR validation. 14d after BDL operation, the expressions of lncRNA NONRATT002335 and NONRATT018085 were significantly up-regulated underlying BDL group compared with control group whereas the expression of lncRNA NONRATT025327, NONRATT000845 and NONRATT001654 had not statistically different between control group and BDL group; The expression of lncRNA NONRATT025415, NONRATT025388 and NONRATT025409 was significantly down-regulated underlying BDL group compared with control group whereas the expression of lncRNA NONRATT02538 and NONRATT006517 had not statistically different between control group and BDL group (Figures [6](#F6){ref-type="fig"} and [7](#F7){ref-type="fig"}).

![Validation of the lncRNAs by RT-qPCR 14d after BDL operation\
The expressions of lncRNA NONRATT002335 and NONRATT018085 were significantly up-regulated underlying BDL group compared with control group; the expression of lncRNA NONRATT025415, NONRATT025388 and NONRATT025409 was significantly down-regulated underlying BDL group compared with control group whereas the expression of lncRNA NONRATT02538 and NONRATT006517 had not statistically different between control group and BDL group.](oncotarget-08-106098-g006){#F6}

![The expression of 10 lncRNAs in T6-T12 spinal cord at different time points after BDL operation\
**(A)** 14d after BDL operation, four up-regulated lncRNAs and five down-regulated lncRNAs were validated by RT-qPCR. **(B)** 28 d after BDL operation, three up-regulated lncRNAs and five down-regulated lncRNAs were validated by RT-qPCR.](oncotarget-08-106098-g007){#F7}

DISCUSSION {#s3}
==========

In the present study, we confirmed that bile duct ligation resulted in obstructive cholestasis and jaundice and this model was consistent with previous reports describing marked elevation of the serum total bilirubin in rats responding to bile duct ligation \[[@R5], [@R25]\]. In addition, our result also indicated that obstructive jaundice induced the decreased sensitivity in response to the mechanical nociceptive stimulation 14d and 28d after BDL operation, which was in line with a previous experimental study showing that obstructive cholestasis by bile duct resection in rodents displayed decreased nociception \[[@R26]--[@R28]\].

We identified the spinal genes and lncRNAs that were differentially expressed between model group and control group by high throughput RNA-seq, providing an important view of spinal genetic heterogeneity for jaundice-induced decreased nociception in rats. The present study identified 2033 differentially expressed lncRNAs in the spinal cord, 488 of which were down-regulated \>2-fold whereas 1545 of which were up-regulated \>2-fold. Similarly, a total of 2800 mRNAs were differentially expressed between control group and BDL group, 1252 of which were down-regulated whereas 1548 of which were up-regulated (FDR\<0.05, \|log2FC\|\>1). Among top 5 up-regulated lncRNAs and top 5 down-regulated lncRNAs, 2 up-regulated (NONRATT002335 and NONRATT018085) and 3 down-regulated lncRNAs (NONRATT025415, NONRATT025388 and NONRATT025409) were identified. These results suggested that 50% differentially expressed lncRNAs were verified by RT-qPCR. Furthermore, we found that Serpina3n was an important up-regulated gene 28d after BDL operation, which were in agreement with a previous study that the serine protease inhibitor Serpina3n was up-regulated in the dorsal root ganglia (DRG) after nerve injury, and attenuated neuropathic pain by inhibiting T cell-derived leukocyte elastase \[[@R29]\].

Previous studies have suggested that the different duration of cholestasis accompanies by some behavioral change in rodents \[[@R26], [@R30]\]. Belghiti et al observed that chronic BDL rats displayed enhanced scratching behavior and thermal hyperalgesia already 48 h after BDL surgery, and this result was perfectly demonstrated by the up-regulation and sensitization of the heat-sensitive TRPV1 channel \[[@R30]\]. Tian et al also demonstrated 5-HT-induced enhanced scratching and antinociception to mechanical and heat stimuli in BDL rats \[[@R31]\], suggesting that targeting 5-HT receptors may be an effective treatment for cholestatic itch. In this study, we found differential expression of some lncRNAs (Figure [7](#F7){ref-type="fig"}) in the spinal cord at different time points (14d/28d) after BDL operation, suggesting that the different lncRNAs in spinal cord segment may be involved in the neuronal response to obstructive jaundice. Although the functions of many lncRNAs in spinal cord are not fully known, our findings provide novel potential insights involving in the molecular mechanism of jaundice-induced altered peripheral nociception.

In conclusion, obstructive jaundice accompanied by altered peripheral nociception is always a crucial factor limiting the therapeutic efficacy of many drugs and quality of life for patients. Here we constructed the expression profiles of lncRNAs and potentially related mRNAs in rats with obstructive jaundice, and found some distinct lncRNA/mRNA expression profiles in spinal cord, suggesting that these unique noncoding transcripts may contribute to the acquisition of cholestasis-induced altered peripheral nociception. Although additional studies are needed to verify these lncRNAs/mRNAs mentioned above, our study provides important insights into novel indicators of treatment for patients with cholestasis.

MATERIALS AND METHODS {#s4}
=====================

Animal care {#s4_1}
-----------

Male Sprague-Dawley rats were provided by the Center of Experimental Animal of Tongji Medical College (license number: 43004700019962). All experimental protocols, animal testing and surgeries were performed in adherence to the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23) revised 1996. The experimental protocols were approved by the committee of experimental animals of Tongji Hospital, Tongji Medical College (IRBID:TJ-A0804). The animals were maintained in a climate controlled room on a 12-hlight/dark cycle (light on at 07:00 h). Rats were housed (2/cage), but they were individually caged during each experiment. Food and water were available *ad libitum*.

Obstructive jaundice model by bile duct ligation {#s4_2}
------------------------------------------------

Rats were placed in a temperature-controlled chamber before experimental operation. All surgical procedures were performed under sterile conditions. Common bile duct ligation (BDL) established the prolonged obstructive jaundice as described in previous studies \[[@R32]--[@R34]\]. After an intraperitoneal injection of ketamine hydrochloride (50 mg/kg) plus xylazine (5 mg/kg), rats which underwent BDL were anesthetized. In those with BDL, the common bile duct was located and ligated using 4-0 silk at two points anterior to the pancreas and posterior to the hilum of the liver. The first ligation was made just above the duodenum and the second almost 2 mm above the first ligation. The bile duct was then transected at the midpoint between the two ligatures. Animals used in this study were sacrificed before signs of severe illness became apparent.

Experimental groups {#s4_3}
-------------------

**Experiment A** Rats were randomly assigned to two groups: (1) Control group (sham-ligation surgery, n = 9); (2) BDL group (common bile duct ligation, n = 9). The mechanical nociceptive thresholds were evaluated at different time points including day (d) 0 (baseline), 3, 7, 14, 21, and 28. 28d after operation, rats were sacrificed, and blood samples, spinal cord tissues were collected for further analysis. Serum total and direct bilirubin levels were measured. Thoracic segments of spinal cord (T6-T12) were prepared to analyze differential gene and lncRNA expression patterns by high-throughput RNA sequencing, and thoracic (T6-T12) segment of spinal cord for Real-Time quantitative PCR (RT-qPCR).

**Experiment B** Rats were randomly assigned to two groups: (1) Control group (n = 12); (2) BDL group (n = 12). 14 days after surgery the T6-T12 spinal cord were collected using a dissection microscope, rinsed with isotonic saline, dissected and fleshly frozen in liquid nitrogen for RT-qPCR.

Assessment of mechanical sensitivity {#s4_4}
------------------------------------

As in previous reports \[[@R35]--[@R38]\], mechanical paw withdraw threshold was examined using the blind method with a minimum of six animals/group. Calibrated von Frey filament apparatus (Stoelting, Wood Dale, IL, USA) was used to measure the paw withdrawal response for a mechanical stimulus. A range of filament comprises 1g, 1.4g, 2g, 4g, 6g, 8g, 10g, and 15g bending force. Rats were allowed to acclimate within a clear plastic chamber over an elevated mesh floor for 30 minutes before assessment at room temperature. Each filament was applied to the midplantar surface of the left hind paw until a withdrawal response occurred. To avoid tissue injury in refractory animals, stimulation was automatically terminated after 15 seconds. The interval between adjacent tests was \>5 minutes. The results of 3 consecutive measurements were averaged for the mechanical paw withdraw threshold in BDL and control rats.

Analysis of jaundice index {#s4_5}
--------------------------

28d following BDL operation, serum total bilirubin levels were determined in the Automated Blood Chemical Analyzer Vitro 350 (Orthoclinical Diagnostic Inc., Rochester, NY).

RNA extraction, library preparation and high-throughput RNA sequencing {#s4_6}
----------------------------------------------------------------------

RNA was isolated from the thoracic (T6-T12) spinal segment tissues in two groups using TRI reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer\'s instructions. Tissue samples were determined using a NanoDrop 2000 (Thermo Fisher Scientific Inc, USA) for integrity, quality and purity.

Library preparation and high-throughput RNA sequencing were performed by the OE Biotechnology Corporation (Shanghai, China) \[[@R39]--[@R41]\]. Total RNA of all samples were sequenced by EMBL GeneCore (EMBL Genomics Core Facility, Heidelberg, Germany). The synthesis of polyadenylated transcriptome libraries for every sample was accompanied by deep sequencing in 3 lanes each generating \>50 million reads pair end. RNA-seq was performed in the two groups, each with three biological replicates.

Real-time quantitative-PCR {#s4_7}
--------------------------

Thoracic (T6-T12) segment of spinal cord were dissected and isolated, and total RNA was extracted using TRIzol reagent (Beijing Tiangen Biotech CO.). 6 μg total RNA was used as a template for cDNA synthesis and amplification using the First-Stand Synthesis System (BioPhotometer, Eppendorf, Hamburg, Germany) according to the manufacturer\'s instructions \[[@R35], [@R42]--[@R45]\]. The primers were designed with the Primer Express 3.0 software (Applied Biosystems), and the specific forward (F) and reverse (R) primer sequences were in Table [4](#T4){ref-type="table"}. Experiments were evaluated in triplicate and repeated at least three times. The threshold cycle (CT) was used to estimate the amount of target mRNA. The comparative CT method with the formula for relative fold-change = 2^−ΔΔCT^ was used to quantify the amplified transcripts.

###### Primer sequences for RT-qPCR

  Gene            Forward (5′ to 3′)       Reversed (5′ to 3′)
  --------------- ------------------------ ------------------------
  NONRATT025327   ATGCACCGCTAGAAGTCACAGA   GCTCAGACCCAGTTGCTCCC
  NONRATT000845   AGTAAACCCCTAACAAATCCCC   GGTCACCTAAGACCATTGGAAA
  NONRATT002335   AGCCATGCGTCTTCCTAACC     AGCACCTGAACAAGCCACCT
  NONRATT018085   ACCAGATGGAACGATTAAACCC   CCACTGCCACTGAACCTTGA
  NONRATT001654   GGGTGGCTGGATTTCATTTT     GGGGAACAGAGGGAATACAACA
  NONRATT025415   CTGGTCTGGGTTTTCCTTCTTG   TGAGGTGGCACAGGTGAGTTT
  NONRATT025388   TCCACTGATTTCCAGGCTCTT    GCCCTTCACTTGACACCTACAC
  NONRATT025409   AGGGCTTGAAGTGGATGGG      TTGCAGTGCTGGCAGAGG
  NONRATT025389   ATTGACTCTGGCCTGGGAGC     TTATGGTGCAAGTGAGGTTGG
  NONRATT006517   ATCCAAAATGATTTCCTACCCA   GACCAGCTATAAGCCAGTGTCC
  GAPDH           CGCTAACATCAAATGGGGTG     TTGCTGACAATCTTGAGGGAG

RT-qPCR: reverse transcriptase quantitative polymerase chain reaction

Data analysis {#s4_8}
-------------

Results are expressed as the mean ± SEM. Statistical comparisons were performed with Mann-Whitney test. Statistical comparisons were performed using unpaired or paired Student\'s t tests or two-way repeated measures ANOVA. P \< 0.05, p \< 0.01, and p \< 0.001 represent statistically significant differences.
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